ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Let's Find a Way to Give Hope to the Spinocerebellar Ataxia (SCA) Community

(BPT) - When Jen's alarm clock sounds the call of a new day, her first steps are not to the coffee machine, but rather to her desk to accomplish anything that might require handwriting. She then turns her attention to any household chores that require her to go upstairs - and hopes to tackle them before noon. When she can return to the first floor of her home where she will remain for the rest of the day, she readies her meals to ensure they require little preparation when hunger strikes. These tasks all need to be done as soon as she rises, because as the clock ticks onward, Jen's mobility will decline. Her handwriting will become illegible, the second floor of her home will become a destination no longer in reach, and her ability to maneuver throughout her kitchen to make food will become an uphill battle she cannot win.

Jen has a form of Ataxia called spinocerebellar ataxia (SCA), a group of rare progressively debilitating neurodegenerative diseases characterized by loss of voluntary motor skills, loss of balance, frequent falling, impaired coordination of arms and legs, and premature death in some cases, among many other symptoms. Despite these symptoms, Jen persists and finds a way to overcome the challenges that SCA poses against her.

Beyond the physical difficulties, one of the most devastating parts of this disease is the generational impact it has on families, where multiple family members (parents, children, aunts, uncles, cousins) are living with SCA, often at the same time. For Jen, losing her mobility throughout the day is a physical burden that pales in comparison to the mental anguish of knowing that her children and grandchildren may inherit the disease. Jen's family has been plagued by a type of SCA for generations, an experience that is all too familiar to many families affected by the disease. This is why Jen is joining the National Ataxia Foundation (NAF) in the "Let's Find A Way" campaign.

It has been more than thirty years since the first specific genetic mutation was discovered for SCA, yet the community waits for the first FDA-approved treatments to become available - and has tired of waiting. The "Let's Find A Way" campaign, inspired by the determination of so many people living with SCA to find a way to overcome the challenges of the disease, aims to raise awareness of the approximately 15,000 people in the U.S. who have no treatment options to slow progression of the disease - and the generations to come who will be subjected to the same fate if no treatments become available.

Though rare diseases like SCA impact a relatively small number of individuals, together they represent a powerful community facing unique and often overwhelming challenges - limited research, delayed diagnoses, and few or no treatment options. Let's find a way to give hope to the SCA and rare disease community by encouraging the FDA to approve safe and effective treatment options. Patients and families deserve the same urgency and access as those affected by more common conditions. Let's find a way to raise awareness of SCA to shine a light on its impact, to drive more research, and to spark greater investment, because rare does not mean invisible. Let's find a way to secure access to treatment, for those like Jen, currently fighting the battle that SCA yields, and for future generations. A future with hope starts with action today.

Join Jen in finding a way by signing and sharing NAF's petition urging the FDA to consider treatment options for rare diseases with unmet needs, including SCA, and visit https://www.ataxia.org/ to learn more about how NAF is working to find a way.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.